先天性肾上腺增生症儿童与青少年生活质量:英国全国多中心评估
该研究在英国14个三级中心对104例先天性肾上腺增生症(CAH)儿童与青少年(55%女性,平均年龄12.7岁,标准差3.0)及其父母进行横断面调查,使用长处与困难问卷(SDQ)和儿科生活质量问卷评估生活质量。父母报告的总分低于常模,而患者自评与常模相似;父母对子女生活质量的评分始终低于子女自评。身高标准差评分较大和体重标准差评分较低与更好的生活质量相关,女孩中较低的类固醇生物标志物与较差的SDQ评分相关。
要点
- 父母报告的CAH儿童生活质量总分低于常模,而患者自评与常模相似。
- 父母对子女生活质量的评分始终低于子女自评。
- 身高较高、体重较低及激素生物标志物提示过度治疗与较差生活质量相关。
核心结论
- 在CAH儿童与青少年中,身高降低、体重增加及激素生物标志物提示过度治疗与较差的生活质量相关;应在临床管理中优先处理这些问题。
研究设计与样本
- 横断面研究,纳入英国14个三级中心的104例CAH儿童与青少年,55%为女性,平均年龄12.7岁(标准差3.0),并有父母配对回答。
主要发现
- 父母报告的总分低于常模,而患者自评与常模相似。
- 患者自评在社会功能方面较好,但在情绪、学校及同伴领域较差;父母报告总分及同伴问题、心理社会、情绪和学校功能领域较差。
- 父母对子女生活质量的评分始终低于子女自评。
- 身高标准差评分较大和体重标准差评分较低与更好的生活质量相关。
- 女孩中较低的类固醇生物标志物与较差的SDQ评分相关。
临床怎么用
- 作者认为,应在临床管理中优先处理身高降低、体重增加及激素生物标志物提示过度治疗的问题。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Quality of life (QoL) has been inconsistently reported in children and young people (CYP) with congenital adrenal hyperplasia (CAH). OBJECTIVE: Assess QoL in CYP with CAH in the UK alongside biometric and androgen profiles. DESIGN: To define the evidence base for health care delivery, we conducted a cross-sectional study in CYP with CAH in the UK. Questionnaire results were compared with normative data and between groups, and modelled for association with sex, height, weight, body mass index, or steroid biomarkers of CAH control. SETTING: Tertiary care in 14 UK centers. PATIENTS: Results from 104 patients, 55% female, mean age 12.7 years (SD 3.0), paired responses from parents. INTERVENTIONS: Strengths and Difficulties questionnaire (SDQ) and pediatric QoL questionnaire. MAIN OUTCOME MEASURE: Total QoL scores as assessed by SDQ and a pediatric QoL questionnaire in comparison to normative data. RESULTS: Total scores were worse in parents than normative data, but similar in patients. Patient QoL was rated better in social functioning but worse in emotional, school, and peer domains by patients, and worse in total scores and domains of peer problems, and psychosocial, emotional, and school functioning by parents. Parents consistently scored QoL of their children lower than their child. Larger height-SD score and lower weight-SD score were associated with better QoL. Girls with lower steroid biomarkers had worse SDQ scores. CONCLUSIONS: In CYP with CAH, reduced height, increased weight, and hormonal biomarkers consistent with overtreatment were associated with worse QoL; addressing these problems should be prioritized in clinical management.Clinical Trials Registration Number: SCH/15/088.
引用
- Lawrence NR, Bacila I, Dawson J, et al. Quality of Life in Children and Young People With Congenital Adrenal Hyperplasia-UK Nationwide Multicenter Assessment. J Clin Endocrinol Metab. 2023. PMID: 37439248. doi:10.1210/clinem/dgad405
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。